GLUL
Glutamine synthetase
Also known as: GLNA_HUMAN, GLNS
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P15104
- Gene
- GLUL
- Ensembl
- ENSG00000135821
- Chromosome
- 1
- Canonical length
- 373 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Mitochondria,Cytosol,Connecting piece
OverviewNCBI Gene
The protein encoded by this gene belongs to the glutamine synthetase family. It catalyzes the synthesis of glutamine from glutamate and ammonia in an ATP-dependent reaction. This protein plays a role in ammonia and glutamate detoxification, acid-base homeostasis, cell signaling, and cell proliferation. Glutamine is an abundant amino acid, and is important to the biosynthesis of several amino acids, pyrimidines, and purines. Mutations in this gene are associated with congenital glutamine deficiency, and overexpression of this gene was observed in some primary liver cancer samples. There are six pseudogenes of this gene found on chromosomes 2, 5, 9, 11, and 12. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Canonical amino-acid sequenceUniProt
373 residues, UniProt reviewed canonical sequence.
>P15104|GLUL
1 MTTSASSHLN KGIKQVYMSL PQGEKVQAMY IWIDGTGEGL RCKTRTLDSE PKCVEELPEW
61 NFDGSSTLQS EGSNSDMYLV PAAMFRDPFR KDPNKLVLCE VFKYNRRPAE TNLRHTCKRI
121 MDMVSNQHPW FGMEQEYTLM GTDGHPFGWP SNGFPGPQGP YYCGVGADRA YGRDIVEAHY
181 RACLYAGVKI AGTNAEVMPA QWEFQIGPCE GISMGDHLWV ARFILHRVCE DFGVIATFDP
241 KPIPGNWNGA GCHTNFSTKA MREENGLKYI EEAIEKLSKR HQYHIRAYDP KGGLDNARRL
301 TGFHETSNIN DFSAGVANRS ASIRIPRTVG QEKKGYFEDR RPSANCDPFS VTEALIRTCL
361 LNETGDEPFQ YKNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GLUL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 1,349 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 1,349 nTPM
- cerebral cortex: 869 nTPM
- retina: 826 nTPM
- adipose tissue: 706 nTPM
- basal ganglia: 672 nTPM
- stomach: 598 nTPM
Single-cell type
- late spermatids: 15,526 nCPM
- müller glia: 5,656 nCPM
- parietal cells: 4,469 nCPM
- kupffer cells: 1,886 nCPM
- early spermatids: 1,797 nCPM
- neutrophils: 1,306 nCPM
Immune cell
- neutrophil: 658 nTPM
- eosinophil: 410 nTPM
- basophil: 397 nTPM
- total PBMC: 172 nTPM
- classical monocyte: 153 nTPM
- intermediate monocyte: 146 nTPM
Brain region
- medulla oblongata: 829 nTPM
- thalamus: 674 nTPM
- white matter: 638 nTPM
- cerebral cortex: 584 nTPM
- midbrain: 584 nTPM
- hypothalamus: 549 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GLUL.
Disease | AllUniProt
Conditions GLUL is implicated in, by any mechanism.
- Glutamine deficiency, congenital (GLND) MIM:610015
- Developmental and epileptic encephalopathy 116 (DEE116) MIM:620806
Disease | GeneticClinVar
13 pathogenic / likely-pathogenic of 283 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Developmental and epileptic encephalopathy 116
- Congenital brain dysgenesis due to glutamine synthetase deficiency
- Glutamine synthetase stabilization disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.19
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.6
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- cell population proliferation
- cellular response to starvation
- L-glutamate catabolic process
- positive regulation of erythrocyte differentiation
- protein palmitoylation
- regulation of endothelial cell migration
- regulation of protein localization to nucleolus
- regulation of sprouting angiogenesis
- response to glucose
- ribosome biogenesis
- glutamine biosynthetic process
- intracellular ammonium homeostasis
Molecular functions
- ATP binding
- identical protein binding
- metal ion binding
- protein-cysteine S-palmitoyltransferase activity
- glutamine synthetase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Glutamine synthetase, catalytic domain
- Glutamine synthetase, N-terminal domain
- Glutamine synthetase/guanido kinase, catalytic domain
- Glutamine synthetase, N-terminal domain superfamily
- Glutamine synthetase, catalytic domain
- Glutamine synthetase, N-terminal conserved site
- Glutamine synthetase, glycine-rich site
- Glutamine Synthetase
- Glutamine synthetase, beta-Grasp domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GLUL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GLUL as an antibody target. Whether an autoantibody or antibody against GLUL could matter depends on whether native GLUL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GLUL is annotated at the cell surface, where native GLUL is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GLUL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...